3,0
17 feb 2012
Ex dipendente
Kenilworth, NJ
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Superb colleagues, excellent drug development programs, amazing legacy, competitive compensation, institutional knowledge still high, excellent corporate citizens, overall management has very good intentions
Svantaggi
patent cliff led to panicked decision making, under the heel of Wall Street, post Schering merger led to period of profound consolidation and ultimately down-sizing...few opportunities for professional growth, lacking a clear emerging markets strategy....China still seems like a mystery to upper management